Table 4.

Residual functional, haemodynamic, and cardiac parameters at 6 month follow up assessment

	Groups			P-values
	Control (n = 20)	Repair (n = 30)	Replace (n = 22)	All groups	Control vs repair	Control vs replace	Repair vs replace
Systolic BP (mmHg)	125 ± 14	126 ± 12	125 ± 15	0.975
Diastolic BP (mmHg)	73 ± 10	80 ± 11	77 ± 11	0.134
Heart rate (bpm)	68 ± 11	75 ± 15	71 ± 8.3	0.141
6MWT distance (m)	393 ± 109	422 ± 82	422 ± 111	0.586
NYHA (mean)	1.45 ± 0.7	1.1 ± 0.3	1.1 ± 0.3	0.087
LVEDVi (ml/m2)	117 ± 28	94 ± 28	94 ± 25	0.005	0.011	0.016	1
LVESVi (ml/m2)	48 ± 15	52 ± 23	52 ± 20	0.863
LVSVi (ml/m2)	69 ± 15	42 ± 9.3	42 ± 8.6	< 0.001	< 0.001	< 0.001	1
LVEF (%)	59 ± 5	47 ± 9.2	46 ± 8.1	< 0.001	< 0.001	< 0.001	1
Effective forward-LVEF(%)	36 ± 8.9	37 ± 8.7	41 ± 8.9	0.241
LVMi (g/m2)	54 ± 11	59 ± 15	60 ± 17	0.307
LA volume indexed (ml/m2)	86 ± 28	67 ± 37	69 ± 28	0.115
MR Rvol (ml)	49 ± 23	19 ± 13	9.5 ± 7.0	< 0.001	< 0.001	< 0.001	0.088
MR RF (%)	39 ± 13	21 ± 11	12 ± 8.0	< 0.001	0.001	< 0.001	0.022
RVEDVi (ml/m2)	92 ± 24	89 ± 18	91 ± 20	0.875
RVESVi (ml/m2)	44 ± 14	48 ± 13	45 ± 12	0.459
RVSVi (ml/m2)	49 ± 15	42 ± 8.6	46 ± 11	0.093
RVEF (%)	53 ± 8	47 ± 6.1	50 ± 5.7	0.011	0.01	0.698	0.224
TR Rvol (ml)	13 ± 17	11 ± 10	12 ± 9.0	0.628
TR RF (%)	15 ± 20	13 ± 11	13 ± 8.8	0.809
RAAi (cm2/m2)	14 ± 3	15 ± 3.6	14 ± 3.6	0.511
Native T1 (ms)*	1012 ± 36	1044 ± 43	1042 ± 37	0.042	0.084	0.068	1
ECV (%)*	27.8 ± 2.2	27.4 ± 3.6	27.0 ± 2.9	0.888
LGE presence**	7 (39%)	14(52%)	11 (55%)	0.634
Non-ischaemic	5 (28%)	11(41%)	10 (50%)	0.698
Ischaemic	2 (11%)	3 (11%)	1 (5%)
LGE (%)**	1.7 ± 2.7	4.3 ± 4.9	3.2 ± 3.7	0.242
LGE (g)**	1.9 ± 3.0	4.0 ± 4.3	3.0 ± 3.5	0.291

^*Analysis performed on patients with paired baseline/follow-up data (control, n = 16; repair, n = 23; replace, n = 20). **Analysis performed on patients with paired baseline/follow-up data (control, n = 18; repair, n = 27; replace, n = 20). Abbreviations as in Tables 1 and 2